Literature DB >> 8266958

Fee structure for investigational drug studies.

J V Anandan1, M J Isopi, A J Warren.   

Abstract

The development and implementation of a fee structure for a pharmacy-coordinated investigational drug service is described. A pilot task and time study established specific time and cost elements for investigational drug services provided by the pharmacy department. To fully assess the costs in dispensing investigational drugs, each research study that used the investigational drug service was broken down into five phases of service. Each phase was further categorized by specific tasks or activities, and a time element to perform each activity or task was determined. Since some studies could require more elaborate randomization of patients, more extensive review of protocols, or more individualized dispensing procedures than others, a range of charges was derived: $2800 for standard protocols to $5700 for more complicated studies. An institutional drug therapy newsletter describing the services and costs was distributed to all medical staff members and principal investigators. The development of a fee structure for an investigational drug service coordinated by the pharmacy department has ensured that pharmacy services are adequately reimbursed and has allowed the department to allocate appropriate personnel to provide the services.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266958

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  2 in total

1.  Cost-evaluation model for clinical trials in a hospital pharmacy service.

Authors:  A Idoate; A Ortega; F J Carrera; A Aldaz; J Giráldez
Journal:  Pharm World Sci       Date:  1995-09-22

2.  Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study.

Authors:  Ala Taji Heravi; Anne Henn; Stefanie Deuster; Stuart McLennan; Viktoria Gloy; Vera Ruth Mitter; Matthias Briel
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.